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Abstract It is mandatory to perform microscopic examina-
tions of bone marrow aspirates during the diagnosis of many
neoplastic haematopoiesis disorders. In 2008, The Interna-
tional Committee for Standardization in Hematology recom-
mended the use of two types of slides for the microscopic
evaluation of bone marrow: wedge-spread film and crush film
slides. Because these techniques have not yet been compared,
we performed such a comparison. Routine bone marrow
samples from 250 patients diagnosed due to different
neoplastic haematological disorders were evaluated. The
major differences between the two compared techniques were
identified in 13 patients with non-Hodgkin’sl y m p h o m a ,
seven patients with systemic mastocytosis and 11 patients
with acute leukaemias or myelodysplastic syndromes or
chronic myelomonocytic leukaemia. Differences were noted
also in many patients with multiple myeloma, but the clinical
significance of these discrepancies was rather modest. The
major causes of the differences observed seemed to be the
dilution of marrow with blood cells and the focal growth of
many neoplastic cells. We believe that the crush technique is
more advantageous compared to the wedge-spread films.
Therefore, we recommend the use of crush films as the
primary method for establishing a diagnosis or for making
therapeutic decisions based on the microscopic examination
of bone marrow.
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Introduction
The microscopic examination of bone marrow remains one
of the key diagnostic procedures in haematology. Accord-
ing to the newest guidelines related to the diagnosis of bone
marrow and lymphatic system malignancies issued by the
World Health Organization (WHO), the importance of
microscopic examinations of bone marrow has not de-
creased; rather, more precise morphological criteria were
defined, where needed, to avoid ambiguity.
For many diseases, more specific immunological or
molecular markers have been discovered, which, when
compared to microscopic examination, allow for a signif-
icantly more precise assessment of atypical cell counts.
Nevertheless, such markers are not available for all
diseases, and microscopic examination remains the only,
or the main, method for diagnosis and monitoring of the
therapy implemented. Also, for diseases where the diagno-
sis is based on genetic methods or immunophenotyping,
periodic microscopic examinations of bone marrow are
needed in order to quickly check for various presentations
of transformation status or secondary dysplastic changes.
The WHO classification sets very high expectations for
cytologists, as the final diagnosis is often based on properly
assessed cellular composition percentages of the bone
marrow. In our clinical practice, assessments of bone
marrow aspirates from the same patient performed in
different laboratories brought different results, although
each of the assessments was performed in the appropriate
manner. These differences were mostly caused by the
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DOI 10.1007/s00277-011-1347-4existence of two slide preparation techniques. The Interna-
tional Committee for Standardization in Hematology
(ICSH) recommends the use of two types of slides for the
microscopic evaluation of bone marrow: wedge-spread film
(technique 1) and crush film (technique 2) slides [1]. The
two techniques mentioned above have not yet been
compared in terms of relevance for diagnostic and
monitoring use in patients with haematological disorders.
The aim of this study was to compare the wedge-spread and
crush film techniques and to determine which of them is
more appropriate for the diagnosis and/or the monitoring of
selected groups of haematological disorders.
Materials and methods
Bone marrow samples were collected from 250 patients
diagnosed and treated in the Department of Hematology
and Transplantology, Medical University of Gdansk. Bone
marrow aspirates were taken from posterior superior iliac
spine in accordance with ICSH guidelines [1]. Only bone
marrow aspirates containing particles were analysed.
Smears from each bone marrow sample were prepared
using both techniques by the same technician, within
maximum of 20 min after aspiration. In technique 1, a
sample was smeared onto the glass slide using the edge of
another glass slide, whereas in technique 2 the particles
were squashed between two slides. After staining by the
May–Grünwald–Giemsa method, the slides were micro-
scopically examined in accordance with the ICSH guide-
lines [1]. In the slides prepared according to technique 1, a
nucleated differential cell count was performed in the areas
just before the marrow particles. In the slides prepared
according to technique 2, only well-spread marrow cells
around the bone marrow particles were analysed. Areas
with significant numbers of damaged cells were avoided.
The marrow cellularity was assessed under ×100 and ×400
magnifications and described as: aplastic, very low, low,
average, high or increased. The same magnifications were
used to assess the megakaryocyte number, described as
follows: lack of megakaryocytes, very low number of
megakaryocytes, low, average, high or very high number of
megakaryocytes. A nucleated differential cell count was
then performed in selected areas (Fig. 1). At least 1,000
cells were counted. The cells were identified according to
generally accepted standards [2–4]. Quantitative assess-
ments of particular cell lineages were performed under
×500 and ×1,000 magnifications. According to the WHO
guidelines, dysplastic changes were qualitatively evaluated
in 200 erythropoietic and granulopoietic cells and in 30
megakaryocytes (where possible) [5]. For each patient,
slides prepared using both techniques were compared and
Fig. 1 Bone marrow smear pre-
pared using technique 1 (a) and
technique 2 (b) at ×100 magni-
fication (upper part of each
picture) and at ×400 magnifica-
tion (lower part of each picture)
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the reasons for any potential differences. In order to avoid
any bias related to assessments carried out by different
operators, all microscopic examinations were performed in
a blinded manner by the same person.
Statistical analysis
The distribution of most variables was not normal (Kolmo-
gorov–Smirnov test, p<0.1). Therefore, the median (range)
was used as a descriptive statistic, and non-parametric tests
were applied to verify the hypotheses. The percentages
of each bone marrow cell population for each technique
were compared using the Wilcoxon test. In the case of
categorical variables (cellularity, megakaryocyte count),
numbers were assigned to each category and the variables
were treated as numerical; p≤0.05 was considered to be
statistically significant.
Results
Bone marrow aspirates from a group of patients were
analysed for the diagnostic procedure, assessment of the
stage of the disease and for treatment monitoring of any
previously diagnosed diseases. Indications for bone marrow
examination are summarized in Table 1.
Non-Hodgkin’s lymphoma
The overall cellularity of the bone marrow was similar
regardless of the smear preparation technique used. The
total percentage of lymphoid lineage cells (excluding
plasma cells) is given in Fig. 2.
Diagnostic value of 12 out of 60 (20%) smears prepared
using technique 1 had a limited adequacy due to significant
dilution by peripheral blood; 1 out of 60 smears (2%) was
considered inadequate for diagnostic purposes. The final
conclusions drawn from the microscopic examinations of
slides from both techniques were in full agreement for 34
(57%) patients. The conclusions for 13 (22%) patients were
slightly different: in seven cases, the smears prepared
according to technique 1 contained peripheral blood, which
made it difficult to conclude whether infiltration was
present or not; in two cases, the smears prepared according
to technique 1 included polymorphic lymphatic cells of
atypical characteristics, which were not confirmed by
technique 2; in three cases for technique 2, a few clusters
of lymphatic cells were observed, which might have been
inflammatory lymphatic aggregates, whereas for technique
1 an increased number of lymphatic cells was not seen; in
the two last cases, they differ in terms of numbers of
eosinophils (1.0% for technique 1 and 5.2% for technique
2) and cellularity (average for technique 1 and hypoplastic
particles with the visible suppression of granulopoiesis for
technique 2), respectively. The details are provided in
Table 2.
Plasma cell (multiple) myeloma
Microscopic examinations of bone marrow samples from
14 patients were performed in order to confirm the first
diagnosis, and from 10 patients to confirm disease
remission. The plasma cell percentages depending on the
technique used are presented for both groups in Fig. 3.
All bone marrow slides prepared according to technique
2 were considered adequate. In 8 out of 24 (33%) slides
prepared according to technique 1, marked dilution by
peripheral blood was noted. In 1 out of 24 (4%) bone
marrow slides prepared according to technique 1, the slide
was considered inadequate (almost a complete lack of
nucleated cells). An increased number of bone marrow
plasma cells were observed in 15 patients. The number of
plasma cells was almost always higher in the slides
prepared by technique 2 compared to technique 1, with
the maximum value being fourfold higher.
Despite differences in the plasma cell counts, the final
conclusions were consistent for both techniques in 21 (88%)
patients.Intheremainingthree(12%)patients, theplasmacell
counts in slides prepared according to technique 1 did not
Table 1 Indications for bone
marrow examination in the pa-
tient study group
Diagnosis/suspicion Diagnostic procedure/staging Treatment monitoring Total
Non-Hodgkin’s lymphoma 60 – 60
Plasma cell myeloma 14 10 24
Chronic lymphocytic leukaemia 21 – 21
Acute leukaemias 18 54 72
Myelodysplastic syndromes 38 – 38
Chronic myelomonocytic leukaemia 5 – 5
Mastocytosis 30 – 30
Total 250
Ann Hematol (2012) 91:497–505 499exceed 10%: 8.2%, 3.0% and 3.4%, respectively, whereas in
slides prepared according to technique 2 the following values
were recorded: 22.3%, 10.2% and 10.2%, respectively.
Systemic mastocytosis
Microscopic examinations of bone marrow samples were
performed in 30 patients to confirm the diagnosis of
systemic mastocytosis (SM). Both techniques differ in
terms of mast cell count (p=0.0007). In 14 out of 30
patients, the mast cell counts were not increased regardless
of the technique used, and there were no atypical mast cell
forms. In this group, SM was finally diagnosed in two
patients by the use of other examinations (i.e. trephine
biopsy, KIT mutation and serum tryptase). In the next 7 out
of 30 patients, the mast cell counts were slightly higher
(range 0.3–0.8%) in slides prepared according to technique
2, which could suggest SM, whereas in slides from 5
patients prepared using technique 1 there were no mast cells
or only a few mast cells were present (≤0.2%), which did
not suggest SM. Slightly increased number of mast cells in
slides prepared according to technique 1 were only more
frequent for two patients (0.4% and 0.7%, respectively),
which could suggest SM. Diagnosis of SM was finally
confirmed in five patients from this group. In the remaining
9 out of 30 patients, who had a later confirmation of an SM
diagnosis, the mast cell counts in slides prepared using
technique 2 were significantly higher, which suggested an
SM diagnosis. A comparison of conclusions from bone
marrow examination using both techniques in the last group
of patients is presented in Table 3.
B-cell chronic lymphocytic leukaemia
Bonemarrowslideswereobtainedfrom21patientsdiagnosed
with B-cell chronic lymphocytic leukaemia (B-CLL). The
percentage of lymphocytic cells did not differ between the
slides prepared using both techniques (Fig. 4).
Lymphocytic infiltration in slides prepared using tech-
nique 2 was often irregular, causing some difficulties in
assessing the percentages of this cell lineage. This
observation, however, had no influence on the final
conclusions, which were either similar or identical in
certain patients.
Fig. 2 Comparison of lymphatic cell percentages (excluding plasma
cells) in the bone marrow smears prepared using technique 1 (white
rectangles) and technique 2 (black rectangles)( open squares median;
white bars/black bars range 25–75%; scale bars min–max)
Table 2 Differences in the conclusions drawn from the microscopic examination of slides prepared according to techniques 1 and 2 in patients
with NHL
No. Technique 1 Technique 2 Infiltration confirmed in
pathological examination
Percentage
lymphocytic cells
Conclusion Percentage
lymphocytic cells
Conclusion
1 8.0 No infiltration 7.8 Focal infiltration Yes
2 5.8 No infiltration 35.5 Focal infiltration Yes
3 11.6 No infiltration 12.2 Focal infiltration, low marrow
cellularity
Not performed
4 9.0 No infiltration 30.8 Wide-spread infiltration Yes
5 16.2 No infiltration 27.9 Focal infiltration Not performed
6 3.6 No infiltration 13.5 Focal infiltration Yes
7 9.4 No infiltration 26.3 Focal infiltration Not performed
8 6.6 No infiltration,
eosinophils −7.8%
29.7 Wide-spread infiltration,
eosinophils—14.8%
Yes
9 15.0 No infiltration, blood
addition
19.5 Focal infiltration,
haemophagocytosis
Not performed
10 17.8 No infiltration 15.3 Focal infiltration Yes
11 18.0 No infiltration 48.3 Wide-spread infiltration Not performed
12 11.9 No infiltration 18.6 Infiltration in 3/5 Not performed
13 6.8 No infiltration 19.5 Infiltration Yes
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myelomonocytic leukaemia
Bone marrow smears from 61 patients with suspected acute
leukaemia, myelodysplastic syndrome or chronic myelo-
monocytic leukaemia were examined. Taking into account
all of the diagnostic procedures, acute leukaemia (AL) was
confirmed in 21 patients (microscopic examination of bone
marrow aspirates was indicative of AL in 21 slides prepared
using technique 2 and 16 slides prepared using technique
1); myelodysplastic syndromes (MDS) was confirmed in 11
patients (microscopic examination of bone marrow aspi-
rates was indicative of MDS in 11 slides prepared using
technique 2 and 10 slides prepared using technique 1) and
chronic myelomonocytic leukaemia (CMML) was diag-
nosed in 5 patients (microscopic examination of bone
marrow aspirates was indicative of CMML in all slides
regardless of the preparation technique). The median
percentages of blast cells in the AL and MDS and CMML
groups differed between the slides prepared using techni-
ques 1 and 2 (Fig. 5).
In the whole group of patients with a diagnosis of a
myeloid neoplasm, major differences depending on the
technique used to prepare the slides were found in 11 cases
(Table 4).
Bone marrow samples from 54 patients were examined to
assess remission status. The aspirates were collected during
various moments of the treatment course. Blast counts were
similar for both slide preparation techniques in patient groups
with acute myeloblastic and lymphoblastic leukaemia. There-
fore, both groups were analysed together. The percentage of
blast cells in slides prepared using technique 1 were in the
range of 0–94.4 (median, 1.1%), while in slides prepared
using technique 2 they were in the range of 0.2–94.1 (median,
1.8%). This difference was significant.
A blast cell percentage >5%, indicating a lack of
cytological remission, was diagnosed in 12 patients when
slides prepared using technique 2 were assessed, and in
only seven patients for the slides prepared using technique
1. Despite the lack of a clear increase in blast cells in slides
prepared using technique 1, a significant increase was
indicated for technique 2 in the slides of five patients. The
numerical values are presented in Table 5.
Discussion
The microscopic examination of bone marrow will long
remain one of the most important diagnostic procedures in
haematology. Therefore, it is very important to be aware
Table 3 Mast cell percentages
in bone marrow samples from
nine patients
The microscopic examination of
slides prepared according to
technique 2 was indicative of
SM/mast cell leukaemia (MCL)
in this group
No. Technique 1 Technique 2
% Mast cells Comments % Mast cells Comments
1 0.4 Few mast cells 4.6 Wide-spread focal infiltrations
2 0.2 Very few mast cells 2.2 Numerous mast cells in focal aggregates
3 10.4 Picture typical of SM 55.7 Mast cell leukaemia
4 0 No mast cells 0.7 Few aggregates of atypical mast cells
5 0 No mast cells 0.9 Aggregates of atypical mast cells
6 8.6 Picture typical of SM 12.1 Picture typical of SM
7 0.4 Few mast cells 4.4 Picture typical of SM
8 0.2 Very few mast cells 5.5 Wide-spread focal infiltrations
9 0.6 Few mast cells 3.6 Numerous mast cells in focal aggregates
Fig. 3 Comparison of plasma
cell percentages in bone marrow
from patients with plasma cell
myeloma (a at the time of
diagnosis; b after therapy);
smears prepared using technique
1( white rectangles) and tech-
nique 2 (black rectangles)( open
squares median; white bars/
black bars range 25–75%; scale
bars min–max)
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istic for different diseases depending on the technique of slide
preparationused.Althoughweindicatedsomedifferencesthat
seemed to depend on the slide preparation technique used in
all groups of neoplastic haematopoietic diseases, not all of
them were clinically relevant. For example, regardless of the
technique used, lymphocytic infiltration was diagnostic for B-
CLL. However, in most of the remaining groups of disorders,
the differences between the results revealed by microscopic
examination that depended on the technique used were of
critical significance.
Non-Hodgkin’s lymphoma
Assessment of lymphocytic infiltration in non-Hodgkin’s
lymphoma during the microscopic examination of bone
marrow is always difficult due to at least two reasons.
Firstly, bone marrow infiltration is often focal; secondly,
some lymphoma cells originating from peripheral lymph
system may relocate to bone marrow with blood, some-
times suggesting infiltration of a limited degree. The
comparison performed indicated that technique 2 was the
more useful for assessing bone marrow infiltration by
lymphoproliferative processes, mostly of focal characteris-
tic, which is in line with the published guidelines [1]. The
conclusion drawn from the slides prepared using this
technique correlated better with the trephine biopsy
examination results. Technique 2 causes certain interpreta-
tion difficulties, particularly when benign lymphocytic
aggregates are present in the bone marrow, which may
appear in both normal bone marrow and bone marrow
affected by inflammatory process. Such aggregates can
differ in size, are well delimited from surrounding haema-
topoietic cells, and mostly consist of numerous mature
lymphocytes, with a few lymphoid cells, histiocytes,
plasma cells and macrophages located among the lympho-
cytes. The frequency of lymphoid aggregates present in
bone marrow aspirates does not usually exceed 20%;
however, in autopsy examinations they were seen in 62%
of biopsies [6, 7]. The cell composition of such lymphoid
cell aggregate can often suggest their character. A high
percentage of more or less polymorphic lymphoid forms,
instead of mature lymphocytes, can indicate malignant
infiltration. Flow cytometry is often cited as a method that
allows verification of the clonal origin of such aggregates
[6]. However, a negative result from flow cytometry
examination does not exclude the fact that neoplastic
lymphoid aggregates might still be present in bone marrow.
Due to the above reasons, the most objective examination
technique for confirming focal lymphoproliferative infiltra-
tion in bone marrow is trephine biopsy [8].
Multiple myeloma
During the last few years, the diagnostic criteria for
multiple myeloma have changed significantly, and currently
the plasma cell percentage in bone marrow is not
considered crucial for confirming the diagnosis. The plasma
cell counts of ≥30% and 10–29%, defined as “major” and
“minor” multiple myeloma criteria (according to the
previous WHO classification), are not used anymore. It is
thought that the plasma cell percentage confirmed during
the first diagnosis in the majority of patients is ≥10%. This
condition is not fulfilled in approximately 10% of patients
with multiple myeloma (MM) [9]. In this study, we showed
that differences in plasma cell percentages are particularly
high depending on the slide preparation technique used as a
consequence of the nature of aggregate growth of plasma
cells in bone marrow. Therefore, routine pathology exami-
nations and the use of technique 2 for microscopic
examinations are fully justified. Currently, in order to
confirm a diagnosis of MM, it is necessary to demonstrate
that plasma cell clone is present in the bone marrow, which
needs other methods, for instance flow cytometry. Flow
Fig. 5 Comparison of blast cell percentages in bone marrow from
patients with AL and MDS and CMML in smears prepared using
technique 1 (white rectangles) and technique 2 (black rectangles)
(open squares median; white bars/black bars range 25–75%; scale
bars min–max)
Fig. 4 Comparison of lymphocytic cells in bone marrow smears
prepared using technique 1 (white rectangles) and technique 2 (black
rectangles) in patients with diagnosed B-CLL. (open squares median;
white bars/black bars range 25–75%; scale bars min–max)
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substitute for microscopic examination [10]. The authors
demonstrated that although flow cytometric evaluation
confirms the presence of plasma cell clones in bone
marrow, the percentage of plasma cells is much lower than
found in morphological examinations, often not exceeding
even 5%. Therefore, it seems justified to not recommend
flow cytometry for assessing the scale of plasma cell
infiltration, which instead should be assessed using patho-
logical examinations or microscopic evaluations with slides
prepared using technique 2.
Systemic mastocytosis
Mast cells, being part of bone marrow stroma, are mainly
localized in bone marrow particles. Thus these cells are
rarely seen at a distance from particles, and if a few distant
mast cells are present in the slide prepared according to
technique 1, it may suggest that the real number of mast
cells in the bone marrow is actually much higher. Such an
increase, however, does not provide any information about
the reason for this increase in mast cell numbers, which
might be due to a reactive inflammatory process. Mast cell
aggregates localized in bone marrow particles strongly
suggest a proliferative process [11]. Such aggregates were
observed in most of the slides prepared using technique 2
that were obtained from patients with a finally confirmed
SM diagnosis. In the slides prepared using technique 1, it
was impossible to recognize such aggregates in non-
squashed bone marrow particles. With only a few available
mast cells, it appears to be impossible to precisely
determine the percentage of atypical forms, which con-
stitutes one of the criteria for an SM diagnosis [12]. This is
why the microscopic examinations for SM should be
performed using slides prepared according to technique 2.
In the slides prepared using technique 1, the bone marrow
picture was generally unclear and ambiguous, with the
changes typical of SM only being seen when significant
infiltration was present. However, it should be stressed that
trephine biopsy remains necessary in every patient sus-
pected of systemic mastocytosis.
Acute leukaemias, myelodysplastic syndromes and chronic
myelomonocytic leukaemia
Microscopic bone marrow examination is absolutely critical
for the diagnosis of AL, MDS and CMML. The previously
used French–American–British classification qualified
these neoplasms based only on cytological and cytochem-
ical characteristics [13, 14]. The diagnostic criteria have
been significantly improved by adding immunophenotyp-
ing, cytogenetic and molecular testing. Many valuable
information gives trephine biopsy examination which
should always be performed when myelodysplastic syn-
drome is suspected. Despite of that, microscopic evaluation
remains crucial for blast cell percentage discrimination.
Additionally, there is no better method for assessing blast
counts in bone marrow. Flow cytometry analysis based on
CD34+ cell counts cannot replace microscopic examination
because not every blast cell expresses the CD34 antigen.
Table 4 Differences in the mi-
croscopic examinations of bone
marrow aspirates depending on
the preparatory technique used
in relation to the type or subtype
of AL, MDS or CMML, as
observed in 11 patients
No. Technique 1 Technique 2
% Blasts Diagnosis/comments % Blasts Diagnosis/comments
1 40.4 AML with maturation 58.0 AML without maturation
2 18.6 MDS–RAEB-2 28.4 AML with multilineage dysplasia
3 18.4 MDS–RAEB-2 31.2 AML with maturation
4 17.2 MDS–RAEB-2 25.4 AML with multilineage dysplasia
5 5.4 MDS–RAEB-1 22.8 AML with multilineage dysplasia
6 15.4 MDS–RAEB-2 32.6 AML with multilineage dysplasia
7 4.8 MDS–RA 12.8 MDS–RAEB-2
8 2.0 Without clear MDS features 16.1 MDS–RAEB-2
9 1.4 Unclear picture 8.2 MDS–RAEB-1
10 3.8 MDS–RCMD 7.0 MDS–RAEB-1
11 8.2 CMML-1 14.1 CMML-2
Table 5 Clinically relevant differences in blast cell percentages in
bone marrow aspirates collected from patients with AL who were
undergoing therapy
No. % Blast cells, technique 1 % Blast cells, technique 2
1 2.2 16.9
2 4.6 61.5
3 3.2 9.6
4 2.2 9.1
5 1.3 12.7
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bone marrow dilution by blood, as well as by bone marrow
fibrosis [15]. The aforementioned limitations may lead to
falsely low percentages of blast cells. The currently used
MDS classification is based not only on confirmation of the
presence of enhanced dysplasia, but also on the number of
blast cells in blood and bone marrow. This latter parameter
is of significant prognostic value, and is included in the
three parameters required for establishment of the Interna-
tional Prognostic Scoring System, which in turn is used to
make therapeutic decisions [16]. Both techniques of slide
preparation were found to be equally sensitive for detecting
dysplastic abnormalities. Technique 2 is advantageous with
respect to platelet lineage assessment: megakaryocyte
counts were generally significantly higher, and details in
the shape of nuclei were easier to see. However, if the
qualitative characteristics of dysplasia are weak, and the
blast count is the dominant abnormality, the use of
technique 1 may lead to false negative results, and will
not enable a diagnosis of MDS to be confirmed. The
differences in blast cell counts in MDS seemed to be related
not only to bone marrow dilution with peripheral blood, but
also to the tendency of blast cells to aggregate into clusters
in bone marrow particles. These particles are clearly visible
in trephine biopsy examinations, usually in more advanced
forms of MDS [15]. Therefore, we believe that technique 2
is more reliable for MDS diagnosis and better correlated to
the clinical picture of patients.
Clinically relevant differences in both techniques of
bone marrow preparation are often related to acute
leukaemias associated with multilineage myelodysplasia,
or to secondary leukaemias. Quite frequently, myelodys-
plastic syndrome, as indicated in slides prepared using
technique 1, is recognized as acute leukaemia in slides
prepared according to technique 2. Taking into account the
possibility of the focal growth of blast cells, for establishing
the subtype of bone marrow hyperplasia (MDS or AML), it
seems appropriate to use the highest percentage of blast
cells from slides prepared using either technique 1 or
technique 2. Such an approach would be consistent with the
recognition criteria of blast cell crises in chronic myeloid
leukaemia [17].
Monitoring the effects of chemotherapy on acute
leukaemia possibly requires the most precise diagnostic
methods, which are mostly based on immunology and/or
molecular techniques. Microscopic examination lost its
significance because it does not usually offer the precision
required by many current therapeutic schemes. In our study,
we showed that it is possible that the assessment of bone
marrow using technique 1 was indicative of remission,
whereas the examination performed in slides prepared using
technique 2 excluded remissions. Flow cytometry exami-
nations should indicate blast counts similar to those found
using technique 1. It should be remembered when making
therapeutic decisions that flow cytometry usually has a
tendency to reveal a lower blast cell count than there might
be in reality.
The results presented confirm that microscopic exami-
nations of bone marrow in patients with one of several
neoplastic haematopoietic disorders may provide different
results depending on the technique used to prepare the
slides. Many of the significant symptoms, easily seen in
slides prepared using technique 2 (i.e. focal lymphocytic or
mast cell infiltrations) might not be observed in slides
prepared using technique 1. On the other hand, in some
specific situations (i.e. presence of villous lymphatic cells),
technique 1 could better preserve single cell morphology.
Therefore we support in full of the ICSH guidelines which
state that microscopic examinations should be performed
using slides prepared according to either technique. We
believe that technique 2 is more advantageous compared to
technique 1. Furthermore, the results obtained using the
slides prepared by technique 2 correlated better with the
clinical picture and trephine biopsy examination results.
Therefore, we recommend the use of technique 2 as the
primary method for establishing a diagnosis or for making
therapeutic decisions based on microscopic examinations of
bone marrow.
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